)
)
Albireo Pharma Investor Relations Material
Latest events
Q3 2022
Albireo Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Albireo Pharma Inc
Access all reports
Albireo Pharma, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company has several product candidates, including BELVIQ®, ALBENZA® and DIFICID®. The company's customers are physicians and patients that use these pharmaceutical products with an integrated sales force that markets directly to non-hospital clinicians (primary care physicians).
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
ALBO
Country
🇺🇸 United States